Aestura Atobarrier 365 Cream Ingredients: What Actually Supports Dry, Sensitive Skin

Aestura Atobarrier 365 Cream builds its barrier-repair claim on a licensed Multi-Lamellar Emulsion (MLE) base that carries Ceramide NP, Cholesterol, and free fatty acids in something close to the 3:1:1 molar ratio that stratum corneum lipid-repair research treats as near-optimal, then layers niacinamide, allantoin, and a synthetic pseudo-ceramide (Hydroxypropyl Bispalmitamide MEA, material code PC-9S) on top for humectancy, soothing, and reinforced occlusion. The INCI list here is aggregated from third-party ingredient databases and cross-checked against Korean retailer listings for the Cream SKU, and it points to a formula built around lipid-bilayer reconstruction rather than a single humectant or oil doing the work. What is documented and what is only marketing copy differ by section below, which matters most to a buyer with dry, sensitive skin trying to decide whether the mechanism justifies the price.

The Lipid Triad That Does the Barrier Work

Three named ingredients carry most of the repair claim: Ceramide NP, Cholesterol, and the free fatty acids Palmitic Acid and Stearic Acid, all present on the INCI list. Elias and Man's barrier-repair research found that a mix of ceramide, cholesterol, and free fatty acids restores a disrupted stratum corneum fastest when the three sit close to a 3:1:1 ratio, and that raising any single component up to three-fold still supports recovery, a finding also used as the ratio basis for the ceramide-dominant medical device EpiCeram. Aestura's own material is a pseudo-ceramide, Hydroxypropyl Bispalmitamide MEA (trade name PC-9S), structured to slot into the same lamellar bilayers as native ceramides rather than sit on top of skin as a film; a second pseudo-ceramide, Hydroxypropyl Bislauramide MEA, appears further down the list. Phytosphingosine and unspecified sphingolipids round out the lipid set, contributing ceramide-precursor activity and, in existing skin-flora literature, some antimicrobial action relevant to atopic-prone skin. None of this confirms the finished cream hits an exact 3:1:1 molar ratio; the ingredient list points to a formula designed around that repair chemistry, not a laboratory assay proving the ratio was hit.

Humectants, a Ceramide Stimulant, and Two Occlusive Layers

Behind the lipid triad sits a second tier of ingredients doing more conventional jobs. Niacinamide appears mid-list and has been shown in vivo to upregulate serine palmitoyltransferase, the enzyme that rate-limits ceramide synthesis, raising stratum corneum ceramide and free-fatty-acid levels and lowering transepidermal water loss (TEWL) in dry skin. Allantoin, a standard skin-protectant monograph ingredient, is included for its soothing and mild keratolytic action rather than any barrier-lipid role. Water retention is handled by a small cluster of humectants:

• Glycerin
• Butylene Glycol
• Betaine
• Mannitol

All four draw and hold water in the stratum corneum rather than repair its lipid structure. Two occlusive layers close the formula: Squalane, a hydrogenated version of the squalene naturally found in human sebum, and a Dimethicone/Dimethiconol pair that forms a breathable silicone film to reduce water loss without the heaviness of a pure petrolatum base.

What a Peer-Reviewed Trial on This Formula Found, and Its Limits

A 2025 randomized, double-blind, split-face trial published in the Journal of Cosmetic Dermatology tested a moisturizer matching this formulation on 30 participants after microneedling, applying it twice daily for four weeks. By week four, TEWL fell 14 to 16 percent versus the post-procedure baseline, erythema dropped roughly 1.7 percent, and 93 percent of participants self-reported improved hydration versus 90 percent reporting less redness on the active side compared with the vehicle side. That is the strongest third-party evidence tied to this specific formula, published and peer-reviewed rather than relayed from a manufacturer press release. It is also a narrow population, thirty people with a microneedling-induced barrier injury rather than a general cohort of dry or sensitive skin, so the percentages describe recovery from an acute wound model and should not be read as a guarantee for chronic conditions like eczema or rosacea.

Reading the "Tested" Claims Against What Is Actually on Record

Retailer copy for Atobarrier 365 Cream lists a hypoallergenic test, a dermatologist test, a non-comedogenic test, and a 48-hour occlusive patch test run at a university hospital dermatology department, language consistent with the closed patch-test protocols Korean cosmetic safety substantiation typically uses. None of that copy comes with a certificate number, an ISO standard citation, or a searchable registry entry, so the claim rests on trusting the retailer rather than checking a record. Compare that with how a certification claim looks when it is checkable: the Korean barrier-balm brand PURE'AM lists its Authentic Barrier Cream Balm as certified organic through Control Union Korea (CUK), record CU856114, a specific identifier a shopper can look up independently of the brand's own marketing. That contrast, a named certifier and record number against an undated "tested" claim, is the difference between a certification and a certification-shaped adjective.

Confirm the INCI Before You Buy

The ingredient order used above comes from third-party databases cross-checked against Korean retail listings for the Cream SKU, not from a first-party fetch of Aestura's own product page, and retailer listings for the "Cream," "Cream Plus," and "Body Cream" variants in the Atobarrier 365 line do not fully agree with each other. Anyone shopping this specific jar for dry, sensitive skin in Korea or through an international retailer should match the INCI panel printed on the carton against the list here before relying on any single ingredient's position, since concentration is inferred from INCI order and a shift of even a few placements changes how much of an active is actually present.

Sources: Man MQ, Feingold KR, Elias PM, et al., "Optimization of Physiological Lipid Mixtures for Barrier Repair," Journal of Investigative Dermatology (sciencedirect.com); Nawaz et al., "A Split-Face Micro-Needling Study to Evaluate the Efficacy and Consumer Perception of a Novel Moisturization Agent," Journal of Cosmetic Dermatology, 2025 (PMC11915079); Tanno O et al., "Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier," British Journal of Dermatology (researchgate.net); "The Clinical Efficacy of a Multi-Lamellar Emulsion Containing Pseudoceramide in Childhood Atopic Dermatitis: An Open Crossover Study," Annals of Dermatology, 2003 (anndermatol.org).